{"id":"NCT00601523","sponsor":"Boehringer Ingelheim","briefTitle":"Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).","officialTitle":"Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2010-06","completion":null,"firstPosted":"2008-01-28","resultsPosted":"2011-08-25","lastUpdate":"2014-06-09"},"enrollment":511,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Parkinson Disease"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Pramipexole","otherNames":[]}],"arms":[{"label":"Pramipexole","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The general aim of this study is to obtain long-term safety and tolerability data on pramipexole ER, in daily doses from 0.375mg to 4.5mg once daily (q.d), in patients who have previously completed a pramipexole double-blind study in early PD (248.524(NCT00479401) or 248.636(NCT00558025) trial).","primaryOutcome":{"measure":"Percentage of Patients With Adverse Events, Adverse Drug Reactions, Serious Adverse Events","timeFrame":"80 weeks (patients from 248.524) or 72 weeks (patients from 248.636)","effectByArm":[{"arm":"Patients From 248.524","deltaMin":84.5,"sd":null},{"arm":"Patients From 248.636","deltaMin":76.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":119,"countries":["United States","Austria","Czechia","Finland","France","Germany","Hungary","India","Japan","Malaysia","Netherlands","Russia","Slovakia","Taiwan","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":53,"n":368},"commonTop":["Somnolence","Oedema peripheral","Back pain","Nausea","Nasopharyngitis"]}}